We collected information about Portola Pharmaceuticals Inc Hours for you. Follow the liks to find out everything about Portola Pharmaceuticals Inc Hours.
https://www.dnb.com/business-directory/company-profiles.portola_pharmaceuticals_inc.f98027d2626e429ca4a5f7cff9a2003d.html
Company Description: Portola Pharmaceuticals is putting blood, sweat, and tears into developing new medications for blood disorders. The company is a global, commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions.
https://craft.co/portola-pharmaceuticals
Portola Pharmaceuticals has 324 employees across 3 locations and $116.64 M in annual revenue in FY 2019. See insights on Portola Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
https://pitchbook.com/profiles/company/42162-58
Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The. Pharmaceuticals. South San Francisco, CA. 408 As of 2019 00000. 0.000 0000-00-00. 000000&0 00000. 00000000. irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
https://thestockmarketwatch.com/stock/?stock=PTLA
PTLA stock quote, chart and news. Get Portola Pharmaceuticals, Inc.'s stock price today.
https://www.reuters.com/legal/litigation/portola-pharmaceuticals-underwriters-lose-bid-toss-shareholder-lawsuit-2021-08-11/
The case is Hayden v. Portola Pharmaceuticals Inc et al., No. 20-cv-00367, U.S. District Court, Northern District of California. For the company: Daniel Kramer of Paul, Weiss, Rifkind, Wharton ...
https://stocktwits.com/symbol/PTLA
Portola Pharmaceuticals Inc. NASDAQ Updated Jul 1, 2020 8:00 PM PTLA 18.03 0.04 (0.22%). 4,834
https://www.crunchbase.com/organization/portola-pharmaceuticals
Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic.
https://en.wikipedia.org/wiki/Portola_Pharmaceuticals
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies. Headquartered and founded in South San Francisco, ...
https://www.businesswire.com/news/home/20200505005333/en/Alexion-Acquire-Portola
May 05, 2020 07:00 AM Eastern Daylight Time. BOSTON & SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Portola Pharmaceuticals, Inc. (NASDAQ:PTLA ...
https://finance.yahoo.com/news/portola-pharmaceuticals-inc-ptla-hedge-143649319.html
Portola Pharmaceuticals Inc (NASDAQ: PTLA) investors should be aware of a decrease in support from the world's most elite money managers recently. …
Searching for Portola Pharmaceuticals Inc Hours?
You can just click the links above. The info is collected for you.
